By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test development firm Genetic Technologies said today it has completed a financing round that raised A$11.7 million (US$12.7 million).

The funds were raised through a private placement of 60 million new shares at A$.195 per share to institutional and private investors in Australia and the US. The offering was oversubscribed and 12 new institutional investors participated in the placement, Genetic Technologies said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.